NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 9,600 shares, a growth of 255.6% from the March 15th total of 2,700 shares. Based on an average trading volume of 46,400 shares, the days-to-cover ratio is presently 0.2 days.

NLS Pharmaceutics Stock Performance

Shares of NLSPW stock opened at $0.00 on Thursday. The business’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01. NLS Pharmaceutics has a one year low of $0.00 and a one year high of $0.07.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).